Shih‐Ping Lin

613 total citations
26 papers, 293 citations indexed

About

Shih‐Ping Lin is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Shih‐Ping Lin has authored 26 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Infectious Diseases and 7 papers in Hepatology. Recurrent topics in Shih‐Ping Lin's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and HIV/AIDS drug development and treatment (6 papers). Shih‐Ping Lin is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and HIV/AIDS drug development and treatment (6 papers). Shih‐Ping Lin collaborates with scholars based in Taiwan, United States and Italy. Shih‐Ping Lin's co-authors include Zhi‐Yuan Shi, Chin-Fu Lin, Chien‐Ching Hung, Hung-Jen Tang, Chia‐Jui Yang, Chun-Eng Liu, Yao‐Wen Chang, Shu‐Hsing Cheng, Yi‐Chien Lee and Yuan‐Ti Lee and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Shih‐Ping Lin

26 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih‐Ping Lin Taiwan 11 139 129 81 49 42 26 293
Jesús Gaytán-Martı́nez Mexico 10 124 0.9× 138 1.1× 61 0.8× 72 1.5× 70 1.7× 33 395
Khurram Rana United States 9 107 0.8× 151 1.2× 75 0.9× 62 1.3× 140 3.3× 19 398
M.‐H. Fievet France 8 149 1.1× 270 2.1× 205 2.5× 10 0.2× 18 0.4× 11 361
Nicole Pagani Italy 10 106 0.8× 204 1.6× 31 0.4× 11 0.2× 212 5.0× 23 422
Andrés Esteban-Cantos Spain 10 88 0.6× 88 0.7× 10 0.1× 100 2.0× 21 0.5× 14 253
Ilaria De Benedetto Italy 9 124 0.9× 92 0.7× 6 0.1× 42 0.9× 55 1.3× 25 274
Georgios Chrysos Greece 8 105 0.8× 99 0.8× 6 0.1× 81 1.7× 99 2.4× 17 241
Ana María Sánchez‐Díaz Spain 9 76 0.5× 209 1.6× 71 0.9× 5 0.1× 99 2.4× 25 397
Vincent Madelain France 10 403 2.9× 154 1.2× 20 0.2× 20 0.4× 3 0.1× 13 516
Innocent Mbulli Ali Cameroon 12 52 0.4× 45 0.3× 13 0.2× 19 0.4× 14 0.3× 42 368

Countries citing papers authored by Shih‐Ping Lin

Since Specialization
Citations

This map shows the geographic impact of Shih‐Ping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Ping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Ping Lin more than expected).

Fields of papers citing papers by Shih‐Ping Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih‐Ping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Ping Lin. The network helps show where Shih‐Ping Lin may publish in the future.

Co-authorship network of co-authors of Shih‐Ping Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shih‐Ping Lin. A scholar is included among the top collaborators of Shih‐Ping Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih‐Ping Lin. Shih‐Ping Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, H.‐C., Shih‐Ping Lin, Duc-Huy T. Nguyen, et al.. (2025). Integrative Roles of Functional Foods, Microbiotics, Nutrigenetics, and Nutrigenomics in Managing Type 2 Diabetes and Obesity. Nutrients. 17(4). 608–608. 5 indexed citations
2.
Chen, Yun‐Wen, et al.. (2023). Appendicitis is associated with an increased risk of systemic lupus erythematosus: a nationwide, population-based, case–control study. Clinical Rheumatology. 42(7). 1783–1791. 3 indexed citations
3.
Wu, Ming‐Ju, Hsin‐Hua Chen, Shih‐Ping Lin, et al.. (2023). Impacts of Huddle Intervention on the Patient Safety Culture of Medical Team Members in Medical Ward: One-Group Pretest-Posttest Design. Journal of Multidisciplinary Healthcare. Volume 16. 3599–3607. 2 indexed citations
7.
Lin, Shih‐Ping, et al.. (2022). Association between a History of herpes zoster and the risk of Sjögren’s syndrome: a nationwide, population-based, case–control study. BMJ Open. 12(10). e061962–e061962. 2 indexed citations
8.
Lee, Yu-Lin, Kuan‐Yin Lin, Shu‐Hsing Cheng, et al.. (2021). Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV. International Journal of Antimicrobial Agents. 58(3). 106403–106403. 6 indexed citations
9.
Lin, Shih‐Ping, Andrea Calcagno, Scott Letendre, & Qing Ma. (2020). Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and Adjuvants. Current topics in behavioral neurosciences. 50. 517–545. 13 indexed citations
10.
Huang, Yu‐Shan, Chun-Eng Liu, Shih‐Ping Lin, et al.. (2019). Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia. AIDS. 33(8). 1345–1351. 14 indexed citations
11.
Lin, Shih‐Ping, et al.. (2019). Influenza With Community-Associated Methicillin-Resistant Staphylococcus Aureus Pneumonia. The American Journal of the Medical Sciences. 358(4). 289–293. 2 indexed citations
12.
Lin, Kuan‐Yin, Hung-Jen Tang, Shih‐Ping Lin, et al.. (2019). Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan. Journal of Microbiology Immunology and Infection. 54(2). 228–237. 15 indexed citations
13.
Shih, Yu‐Lueng, et al.. (2019). YC-1 Antagonizes Wnt/β-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma. Cancers. 11(5). 661–661. 7 indexed citations
14.
Li, Chia‐Wen, Chia‐Jui Yang, Hsin‐Yun Sun, et al.. (2018). Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan. PLoS ONE. 13(3). e0194149–e0194149. 18 indexed citations
15.
Lin, Te‐Yu, Chia‐Jui Yang, Hung-Jen Tang, et al.. (2018). Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study. Journal of Microbiology Immunology and Infection. 52(5). 700–709. 10 indexed citations
16.
Lee, Yu-Lin, Kuan‐Yin Lin, Chien‐Yu Cheng, et al.. (2017). Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan. PLoS ONE. 12(10). e0186338–e0186338. 14 indexed citations
17.
Lin, Kuan‐Yin, Chien‐Yu Cheng, Chia‐Wen Li, et al.. (2017). Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up. PLoS ONE. 12(6). e0179870–e0179870. 35 indexed citations
19.
Lin, Shih‐Ping, et al.. (2011). Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates. Journal of Microbiology Immunology and Infection. 45(3). 200–207. 41 indexed citations
20.
Lin, Shih‐Ping & Yao‐Wen Chang. (2003). A novel framework for multilevel routing considering routability and performance. 11. 44–50. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026